Damora Therapeutics, Inc.

DMRA·NASDAQ·$25.89Share Price as of 11/2·$2BMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/10/26 10-QQ1 ended 03/31/2605/12/26 10-KFY 202503/19/26 10-QQ3 ended 09/30/2511/06/25 10-QQ2 ended 06/30/2508/05/25

Disclosures

8-KCurrent report07/20/26 8-KCurrent report06/17/26 8-KCurrent report05/04/26 8-KCurrent report04/20/26 8-KCurrent report03/23/26

Prospectuses and Registrations

POS AMPost-effective amendment08/10/26 POSASRProspectus / registration08/10/26 S-8 POSPost-effective amendment (S-8)08/10/26 S-8 POSPost-effective amendment (S-8)08/10/26 S-8 POSPost-effective amendment (S-8)08/10/26

Proxies

DEF 14ADefinitive proxy04/29/26 DEFA14AAdditional proxy materials04/29/26 DEF 14ADefinitive proxy12/31/25 PRE 14APreliminary proxy12/16/25 DEF 14ADefinitive proxy04/30/25

Ownership

Form 4Insider transaction09/28/26 Form 3Initial insider ownership08/13/26 Form 4Insider transaction08/13/26 144Proposed sale of securities08/06/26 Form 4Insider transaction07/07/26

Other

EFFECTRequest for effectiveness08/12/26 8-A12B/A8-A12B/A08/10/26 ARSAnnual report to shareholders05/01/26 EFFECTRequest for effectiveness12/23/25 CORRESPCorrespondence with the SEC12/22/25